Kiran Verukonda Ravi, Zhu Tong Ying, Yip Terence, Lui Sing Leung, Lo Wai Kei
Care Hospitals, Hyderabad, Andhra Pradesh, India; Huashan Hospital, Fudan University, Shanghai, PR China; and Dr. Lee Iu Cheung Memorial Renal Centre, Department of Medicine, Tung Wah Hospital, Hong Kong SAR, PR China.
Perit Dial Int. 2014 Jun;34(4):390-8. doi: 10.3747/pdi.2013.00055. Epub 2014 Feb 4.
Obesity increases mortality in the general population, but improves survival in hemodialysis patients. In peritoneal dialysis (PD) patients, the reported effect is controversial. We investigated the effect of body mass index (BMI) on patient survival in Asian PD patients.
The survival of incident Asian PD patients from 2001 to 2008 in a single center in Hong Kong was analyzed retrospectively. Baseline demographic and clinical data were collected from patient records. Patients who had a total Kt/V below 1.7 or who died within 6 months were excluded. The BMI was categorized using the World Health Organization recommendation for Asian populations.
In the 274 study patients [154 men (56%); 138 with diabetes (50.4%); mean age: 63.4 ± 14.6 years; mean BMI: 21.97 ± 3.23 kg/m(2); 37 underweight (13.5%); 35 obese (12.8%)], the relative risk (RR) for mortality [adjusted for age, diabetes status, and cardiovascular disease (CVD)] was similar for the normal and overweight groups, but higher for the underweight (RR: 1.909; p = 0.028) and obese groups (RR: 1.799; p = 0.048). The increased mortality in obese patients was more prominent in patients with diabetes (RR: 1.9 vs 1.19 in patients without diabetes; p = 0.074 and 0.76 respectively), and in patients with CVD (RR: 8.895 vs 1.642 in patients without CVD; p = 0.012 and 0.122 respectively).
In Asian PD patients, the relationship between BMI and mortality was U-shaped, with higher mortality in the underweight and obese patients. The negative impact of obesity was more prominent in patients with diabetes and CVD.
肥胖会增加普通人群的死亡率,但可提高血液透析患者的生存率。对于腹膜透析(PD)患者,所报道的影响存在争议。我们研究了体重指数(BMI)对亚洲PD患者生存的影响。
回顾性分析了2001年至2008年在香港一家单一中心的初治亚洲PD患者的生存情况。从患者记录中收集基线人口统计学和临床数据。排除总Kt/V低于1.7或在6个月内死亡的患者。根据世界卫生组织针对亚洲人群的建议对BMI进行分类。
在274例研究患者中[154例男性(56%);138例患有糖尿病(50.4%);平均年龄:63.4±14.6岁;平均BMI:21.97±3.23kg/m²;37例体重过轻(13.5%);35例肥胖(12.8%)],正常体重和超重组的死亡相对风险(RR)[根据年龄、糖尿病状态和心血管疾病(CVD)进行调整]相似,但体重过轻组(RR:1.909;p = 0.028)和肥胖组(RR:1.799;p = 0.048)更高。肥胖患者死亡率的增加在糖尿病患者中更为显著(有糖尿病患者的RR为1.9,无糖尿病患者为1.19;p分别为= 0.074和0.76),在患有CVD的患者中也更为显著(有CVD患者的RR为8.895,无CVD患者为1.642;p分别为= 0.012和0.122)。
在亚洲PD患者中,BMI与死亡率之间的关系呈U形,体重过轻和肥胖患者的死亡率更高。肥胖的负面影响在糖尿病和CVD患者中更为突出。